You just read:

Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea

News provided by

Foamix Pharmaceuticals Ltd.

Sep 12, 2016, 07:00 ET